PUMA BIOTECHNOLOGY, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $20.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-02-26
- PUMA BIOTECHNOLOGY, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was $20.00K.
- PUMA BIOTECHNOLOGY, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2020 was $13.66M, a 37.44% decline from fiscal 2019.
- PUMA BIOTECHNOLOGY, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2019 was $21.83M, a 99.73% increase from fiscal 2018.
- PUMA BIOTECHNOLOGY, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2018 was $10.93M.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month |
|---|---|
| 2025-12-31 | $20.00K 10-K · filed 2026-02-26 |
| 2020-12-31 | $13.66M 10-K · filed 2021-03-01 |
| 2019-12-31 | $21.83M 10-K · filed 2021-03-01 |
| 2018-12-31 | $10.93M 10-K · filed 2021-03-01 |
| 2017-12-31 | -$1.40M 10-K · filed 2020-02-28 |
| 2016-12-31 | $6.15M 10-K · filed 2019-03-01 |
| 2015-12-31 | $4.22M 10-K · filed 2018-03-09 |
| 2014-12-31 | $9.96M 10-K · filed 2017-03-01 |
| 2013-12-31 | -$806.00K 10-K · filed 2016-02-29 |
| 2012-12-31 | $346.00K 10-K · filed 2015-03-02 |
| 2011-12-31 | $24.00K 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |